Synthetic lethality of PARP inhibition in BRCA-network disrupted tumor cells is associated with interferon pathway activation and enhanced by interferon-γ
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthetic lethality of PARP inhibition in BRCA-network disrupted tumor cells is associated with interferon pathway activation and enhanced by interferon-γ
Authors
Keywords
-
Journal
APOPTOSIS
Volume 17, Issue 7, Pages 691-701
Publisher
Springer Nature
Online
2012-03-06
DOI
10.1007/s10495-012-0707-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic
- (2011) Timothy A. Yap et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PARP inhibitors stumble in breast cancer
- (2011) Malini Guha NATURE BIOTECHNOLOGY
- Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer
- (2011) Joyce O'Shaughnessy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells
- (2011) A. G. Patel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo
- (2010) V. J. Weston et al. BLOOD
- BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair
- (2010) P. J. O'Donovan et al. CARCINOGENESIS
- Guiding the “misguided” - functional conditioning of dendritic cells for the DC-based immunotherapy against tumours
- (2010) Fang-Ping Huang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interferon-Lambda: A New Addition to an Old Family
- (2010) Raymond P. Donnelly et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- IFN Restores Breast Cancer Sensitivity to Fulvestrant by Regulating STAT1, IFN Regulatory Factor 1, NF- B, BCL2 Family Members, and Signaling to Caspase-Dependent Apoptosis
- (2010) Y. Ning et al. MOLECULAR CANCER THERAPEUTICS
- ATM Deficiency Sensitizes Mantle Cell Lymphoma Cells to Poly(ADP-Ribose) Polymerase-1 Inhibitors
- (2010) C. T. Williamson et al. MOLECULAR CANCER THERAPEUTICS
- Identification and SAR of novel pyrrolo[1,2-a]pyrazin-1(2H)-one derivatives as inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1)
- (2009) Giovanna Pescatore et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Conditional interleukin-12 gene therapy promotes safe and effective antitumor immunity
- (2009) H Komita et al. CANCER GENE THERAPY
- Regulation of apoptosis by type III interferons
- (2008) W. Li et al. CELL PROLIFERATION
- A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor
- (2008) Nicholas C Turner et al. EMBO JOURNAL
- -H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin
- (2008) A. Kinner et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More